SUB: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for re-appointment of the Sh. N.R Munjal as Chairman & Managing Director;
Dear Sir,
Pursuant to the provisions of Regulation 30 and any other applicable provisions, if any, of the Securities and Exchange of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (hereinafter "SEBI Listing Regulations") please note that the Board of Directors in their meeting held on today i.e. 10th August, 2022, have considered and approved the reappointment of and payment of remuneration to Sh. N.R Munjal (DIN 00015096), Chairman & Managing Director of the company for a period of next five years w.e.f. 23rd March, 2023 as recommended by Nomination and Remuneration Committee, Subject to the approval of the Shareholders of the Company.
Pursuant to the SEBI Circular CIR/CFD/CMD/4/2015 dated September 9, 2015, the brief profile of the Sh. N.R Munjal is enclosed herewith.
You are requested to kindly take the same on record.
Thanking you,
Encl: As above
Details under Regulation 30 of Listing Regulations read with clause 7 of Annexure I of SEBI Circulardated September 9, 2015
BRIEF PROFILE OF SHRI. NAVRATTAN MUNJAL CHAIRMAN & MANAGING DIRECTOR
Name of the Director
Sh. Navrattan Munjal (DIN: 00015096)
Date of re-appointment
The Current term of Sh. Navrattan Munjal Chairman &
Managing Director is going to expire on 22nd March 2023.
Sh. Navrattan Munjal has been proposed to be
reappointed as Chairman & Managing Director of the
Company for a period of next five year w.e.f 23rd March
2023 subject to the approval of shareholder in ensuing
Annual General meeting of the Company.
Type
Chairman & Managing Director
Age
70 Years
Date of Appointment
Re-appointment with effect from 23rd March, 2023.
Qualification
Graduate
Expertise
Sh. N.R. Munjal, Chairman & Managing Director is a key
part of the 35 years old Ind-Swift Group and more than 30
years of vast experience in the area of long term strategy
formulation, leading and monitoring the senior
management in implementation of Business plans for the
company, Exploring new and innovative avenues for
business growth of the group, Mentoring and ensuring the
setting up of a conducive culture for the Company.
Directorships held in other Companies
IND SWIFT LIMITED
NIMBUA GREENFIELD (PUNJAB) LIMITED
ESSIX BIOSCIENCES LIMITED
MOHALI GREEN ENVIRONMENT PRIVATE LIMITED
No. of Equity Shares held in the Company
9,20,724 equity shares of Rs. 10 each
Information as required pursuant to BSE
Sh. Navrattan Munjal is not debarred from holding the
Circular with ref. no.
office of director by virtue of any SEBI order or any other
LIST/COMP/14/2018-19
such authority.
Relationship Between Directors/ KMP
Sh. Navrattan Munjal is father of Mr. Sahil Munjal who is an
inter-se
Executive Director of the Company.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Ind-Swift Laboratories Ltd. published this content on 10 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 August 2022 17:30:05 UTC.
Ind-Swift Laboratories Limited is an India-based company. The Company is engaged in the business of manufacturing intermediates and formulations. The Companyâs products or services include Advanced Intermediates. It is API partner for many organizations both in generic and innovative domains. The Company offers reference standards and impurities for various active pharmaceutical ingredients (APIs) under British Pharmacopoeia (BP), European Pharmacopoeia (EP), British Pharmacopoeia (BP) and others. Its impurity portfolio is stocked with a range of standards for supply. The Company offers reference standards and impurities for over 25 APIs. All impurities are shipped with full documentation, including a Certificate of Analysis and MSDS. The research center, spread over the area of 40,000 square feet, is engaged in developing process technology for APIs in different therapeutic categories.